Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide
Loredana Serpe, Margherita Gallicchio, Roberto Canaparo, Franco DosioDepartment of Drug Science and Technology, University of Turin, ItalyAbstract: Among the gynecological malignancies, ovarian cancer is the leading cause of mortality in developed countries. Treatment of ovarian cancer is based on s...
Saved in:
Main Authors: | Serpe L (Author), Gallicchio M (Author), Canaparo R (Author), Dosio F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer
by: Luyckx M, et al.
Published: (2014) -
Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity
by: Federica Foglietta, et al.
Published: (2022) -
Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization
by: Klaudia Siwowska, et al.
Published: (2017) -
Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
by: Christian Dohmen, et al.
Published: (2012) -
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
by: Brueseke TJ, et al.
Published: (2013)